Selective Screening of Dual‐Target Bioactive Constituents From Shaoqitongfei Formula Against Chronic Obstructive Pulmonary Disease by Receptor Chromatography
Journal of Separation Science · 2026
DOI: 10.1002/jssc.70535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2026. Verfasst von Yunshan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, …. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Drugs, Chinese Herbal, Receptor, Muscarinic M3, Receptors, Adrenergic, beta-2. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province.
Themen: COPD
Abstract (Originalsprache)
Current mainstream treatment of chronic obstructive pulmonary disease (COPD) relies largely on long‐acting β 2 ‐adrenergic receptor (β 2 AR) agonists and muscarinic M 3 receptor (M 3 R) antagonists, yet residual inflammation and variable treatment responses persist. Developing therapeutics from multicomponent herbal medicines is an effective drug development approach but is constrained by the difficulty of linking individual constituents to pharmacologically relevant targets and in vivo efficacy. This study established an integrated discovery workflow combining whole‐formula efficacy testing, receptor‐affinity chromatography, mass spectrometry (MS), and in vivo validation of candidate combinations. We applied this workflow to the Shaoqitongfei formula (SQTF), an investigator‐developed three‐herb prescription evaluated for ameliorating COPD, and selected the β 2 AR and M 3 R as clinically relevant bronchodilator targets. In porcine pancreatic elastase/lipopolysaccharide (LPS)‐induced COPD mice, SQTF improved respiratory parameters, attenuated lung injury, and reduced inflammatory cytokine levels in serum and bronchoalveolar lavage fluid. Affinity columns containing immobilized β 2 AR and M 3 R stationary phases were utilized to screen the receptor‐targeting components in formula extract. High‐performance liquid chromatography‐tandem MS analysis tentatively annotated albiflorin and kaempferol in the extract retained by both columns. In rats exposed to cigarette smoke and LPS, co‐administration of albiflorin and kaempferol reproduced several of the pulmonary and anti‐inflammatory effects of SQTF and shifted protein‐expression patterns associated with signaling proteins to those observed in controls. Taken together, these findings establish a receptor‐guided workflow for selecting pharmacologically relevant constituent combinations from complex herbal medicines and provide an analytical basis for the further development of SQTF‐derived therapies for COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Wang, Y., Zhang, Y., Li, K., Wang, Z., Wang, J., & Li, Q. (2026). Selective Screening of Dual‐Target Bioactive Constituents From Shaoqitongfei Formula Against Chronic Obstructive Pulmonary Disease by Receptor Chromatography. Journal of Separation Science. https://doi.org/10.1002/jssc.70535
Vancouver
Wang Y, Zhang Y, Li K, Wang Z, Wang J, Li Q. Selective Screening of Dual‐Target Bioactive Constituents From Shaoqitongfei Formula Against Chronic Obstructive Pulmonary Disease by Receptor Chromatography. Journal of Separation Science. 2026. doi:10.1002/jssc.70535
BibTeX
@article{Wang2026,
author = {Wang, Yunshan and Zhang, Yangyang and Li, Kexin and Wang, Zihu and Wang, Jia and Li, Qian},
title = {Selective Screening of Dual‐Target Bioactive Constituents From Shaoqitongfei Formula Against Chronic Obstructive Pulmonary Disease by Receptor Chromatography},
journal = {Journal of Separation Science},
year = {2026},
doi = {10.1002/jssc.70535}
}
EUVIMED